Cargando…
Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom.
In 1999, 23% of Salmonella enterica serotype Typhi isolates from patients in the United Kingdom exhibited decreased susceptibility to ciprofloxacin (MIC 0.25-1.0 mg/L); more than half were also resistant to chloramphenicol, ampicillin, and trimethoprim. Increasing numbers of treatment failures have...
Autores principales: | Threlfall, E J, Ward, L R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631792/ https://www.ncbi.nlm.nih.gov/pubmed/11384525 |
Ejemplares similares
-
Molecular fingerprinting of multidrug-resistant Salmonella enterica serotype Typhi.
por: Hampton, M D, et al.
Publicado: (1998) -
Ciprofloxacin-Resistant Salmonella enterica Serotype Typhi, United States, 1999–2008
por: Medalla, Felicita, et al.
Publicado: (2011) -
Induction of resistant mutants of Salmonella enterica serotype Typhi under ciprofloxacin selective pressure
por: Dahiya, Sushila, et al.
Publicado: (2014) -
Antimicrobial Susceptibility Patterns of Salmonella enterica Serotype Typhi in Eastern Nepal
por: Khanal, Basudha, et al.
Publicado: (2007) -
Emergence of Ciprofloxacin-Resistant Salmonella enterica Serovar Typhi in Italy
por: García-Fernández, Aurora, et al.
Publicado: (2015)